Breaking News

Frontage Appoints Clinical Services SVP

May 13, 2014

To expand clinical operations

Eileen McAuley, RN, MPA was named senior vice president, Clinical Services at Frontage. She brings more than 25 years of clinical operations experience, from project management coordination of functional research components to strategic leadership.
 
Ms. McAuley most recently served as chief operating officer of Integrium, a therapeutically-focused, full-service CRO. Previously, she was senior director of Clinical Operations for Alteon, a biotechnology company focused on development of novel treatments for cardiovascular diseases.
 
“We are delighted to welcome Eileen McAuley to our senior leadership team at Frontage. She has exceptional skills in developing sustainable organizational growth, and can offer our clients guidance to effectively manage clinical research programs across multiple therapeutic areas,” said Carlos Orantes, chief operating officer of Frontage Labs. “Ms. McAuley’s leadership abilities and experience will enable Frontage to enhance our service offerings and the overall value we deliver to our clients as we keep pace with the growing complexity of clinical development.”
 
Additionally, Frontage plans to expand its clinical research operations with a new 33,000 sq.-ft. clinical research center in Secaucus, NJ, scheduled to open late in 2014. The new facility will include enhancements to conduct a wider range of clinical studies, as well as multiple, concurrent studies, and will nearly triple the company’s clinical capacity in the U.S.
 
“By expanding our investment and infrastructure in clinical services, Frontage will be well-positioned to comprehensively support the early development needs of our clients,” said Song Li, chief executive officer of Frontage.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important